The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HDFC Mutual Fund

October 30, 2026 Mr. Maneesh Sharmabharosa apno ka Company Secretary & Compliance Officer Piramal Pharma Limited Ananta Building, Piramal Corporate Park Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai - 400070 Tel. No. - 022-38023000 Fax No. - 022-38023884 Dear Sir, Sub: Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations. 2011 We refer to our letter dated July 16, 2026 wherein we had mentioned that as On July 14, 2026, the aggregate holding of the Schemes of HDFC Mutual Fund in "Piramal Pharma Limited" ("The Company") was 7.015% of the paid up equity share capital of the Company (Paid up Equity Share Capital being Rs. 13,31,34,81,300/- comprising 1,33,13,48,130 Equity Shares of Rs. 10/-each). Further, in accordance with the captioned regulation and other applicable laws / regulations, if any, we wish to inform you that there has been a decrease in the shareholding of the Company by the Schemes of HDFC Mutual Fund by 2.027% as of October 28, 2026. As on October 28, 2026 the aggregate holding of the Schemes of HDFC Mutual Fund in the Company is 4.988% of the paid up equity share capital of the Company (Paid up Equity Share Capital being Rs. 13,31,34,81,300/- comprising 1,33,13,48,130 Equity Shares of Rs. 10/- each). As per Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 please find enclosed the details of change in the shareholding in the prescribed format enclosed as Annexure 1. Kindly acknowledge receipt of the same. Thanking you, Yours faithfully, For HDFC Asset Management Company Limited Dinesh Bhakade Lead - Compliance Governance End: As above Listing Department Listing Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Phiroze Jeejeebhoy Towers Bandra - Kurla Complex Dalai Street, Bandra (E), Mumbai - 400 051. Mumbai-400 001. Tel.: 022- 2659 8190 Fax: 022- 2659 8191 Fax:022-2272 3121 HDFC Asset Management Company Limited CIN No.: L65991MH1999PLC123027 Registered Office : "HDFC House", 2nd Floor, H.T. Parekh Marg, 165-166, Backbay Reclamation, Churchgate, Mumbai - 400 020 Tel.: 91-22-6631 6333 Website : www.hdfcfund.com Annexure-1 BHAROSA APNO KA Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company (TC) PIRAMAL PHARMA LIMITED Name(s) of the acquirer and Persons HDFC Mutual Fund: Acting in Concert (PAC) with the HDFC Trustee Company Limited A/c - acquirer HDFC BSE 500 ETF HDFC BSE 500 Index Fund HDFC Flexi Cap Fund HDFC NIFTY500 MULTICAP 50:25:25 INDEX FUND HDFC NIFTY SMALLCAP 250 ETF HDFC NIFTY SMALLCAP 250 INDEX FUND Whether the acquirer belongs to NO Promoter/ Promoter group Name(s) of the Stock Exchange(s) where BSE Limited the shares of TC are Listed National Stock Exchange of India Limited Details of the acquisition / disposal as Number % w.r.t. total % w.r.t. total follows share/ voting diluted share/ capital voting capital of wherever the TC (**) applicable (*) Before the acquisition under consideration, holding of: a) Shares carrying voting rights 9,33,93,655 7.015 N.A b) Shares in the nature of encumbrance N.A (pledge/ lien/non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by N.A shares d) Warrants/ convertible securities/ any N.A other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 9,33,93,655 7.015 N.A Details of Acquisition/Sale: a) Shares carrying voting rights 2,69,92,907 2.027 N.A acquired/sold b) VRs acquired /sold otherwise than by 0 N.A shares c) Warrants/convertible securities/any N.A other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered/invoked/released 0 N.A by the acquirer e) Total (a+b+c+/-d) 2,69,92,907 N.A Page 1 of 2 Annexure-1 BHAROSA APNO KA Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 After the Acquisition/Sale, holdinq of: a) Shares carrying voting rights 6,64,00,748 4.988 N.A b) Shares encumbered with the acquirer 0 0 N.A c) VRs otherwise than by shares 0 0 N.A d) Warrants/convertible securities/any 0 0 N.A other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition. e) Total (a+b+c+d) 6,64,00,748 4.988 N.A Mode of acquisition/sale (e.g. open Open Market market / off-market / public issue / rights issue / preferential allotment / inter-se transfer etc). Date of acquisition/sale of shares / VR or October 28, 2026 date of receipt of intimation of allotment of shares, whichever is applicable Equity share capital / total voting capital Rs. 13,31,34,81,300/- comprising 1,33,13,48,130 of the TC before the said acquisition/sale equity shares of Rs. 10/- each. Equity share capital/total voting capital of Rs. 13,31,34,81,300/- comprising 1,33,13,48,130 the TC after the said acquisition/sale equity shares of Rs. 10/- each. Total diluted share/voting capital of the N.A. TC after the said acquisition/sale (*) Total share capital/ voting capital has been taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. /**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. For HDFC Asset Management Company Limited (Investment Manager for the Schemes of HDFC Mutual Fund) Dinesh Bhakade Lead - Compliance Governance Place: Mumbai Date: October 30, 2026 Page 2 of 2